Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 2, 2013, Pages 284-289

  Jun, Chung Hwan ^a   Ki, Ho Seok ^a   Lee, Hoon Ki ^a   Park, Kang Jin ^a   Park, Seon Young ^a   Cho, Sung Bum ^a   Park, Chang Hwan ^a   Joo, Young Eun ^a   Kim, Hyun Soo ^a   Choi, Sung Kyu ^a   Rew, Jong Sun ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Carcinoma; Chemoembolization; Fever; Hepatocellular; Prognosis; Progression free survival; Therapeutic

Indexed keywords

ADM; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; DOXORUBICIN; IODINATED POPPYSEED OIL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FEVER; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PORTAL VEIN THROMBOSIS; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; THERAPY EFFECT; TUMOR VOLUME;

EID: 84873667689     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i2.284     Document Type: Article

References (25)

1. Yang JD, Roberts LR. Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-458[PMID: 20628345 DOI: 10.1038/nrgastro.2010.100]
2. Park JW. [Hepatocellular carcinoma in Korea: introduction and overview]. Korean J Gastroenterol 2005; 45: 217-226[PMID: 15843747 DOI: 200504302]
3. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699[PMID: 8594428 DOI: 10.1056/ NEJM199603143341104]
4. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002; 359: 1734-1739[PMID: 12049862 DOI: 10.1016/S0140- 6736(02)08649-X]
5. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology 2004; 127: S179-S188[PMID: 15508083 DOI: S0016508504016117]
6. Llovet JM, Bruix J, Gores GJ. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology 2000; 31: 1019-1021[PMID: 10733561 DOI: 10.1053/he.2000.6959]
7. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival. Hepatology 2003; 37: 429-442[PMID: 12540794 DOI: 10.1053/jhep.2003.50047]
8. Okada S. Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues. Hepatology 1998; 27: 1743-1744[PMID: 9620352 DOI: 10.1002/ hep.510270639]
9. Matsuda Y, Kawata S, Nagase T, Maeda Y, Yamasaki E, Kiso S, Ishiguro H, Matsuzawa Y. Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor. Cancer 1994; 73: 53-57[PMID: 8275438]
10. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. N Engl J Med 1995; 332: 1256-1261[PMID: 7708069 DOI: 10.1056/NEJM199505113321903]
11. Chan AO, Yuen MF, Hui CK, Tso WK, Lai CL. A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma. Cancer 2002; 94: 1747-1752[PMID: 11920537 DOI: 10.1002/cncr.10407]
12. Takayasu K, Arii S, Matsuo N, Yoshikawa M, Ryu M, Takasaki K, Sato M, Yamanaka N, Shimamura Y, Ohto M. Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma. AJR Am J Roentgenol 2000; 175: 699-704[PMID: 10954453]
13. Boix J, Lorenzo-Zúñiga V, Moreno de Vega V, Domènech E, Gassull MA. Endoscopic resection of ampullary tumors: 12-year review of 21 cases. Surg Endosc 2009; 23: 45-49[PMID: 18398649 DOI: 10.1007/s00464-008-9866-3]
14. Kanematsu T, Furuta T, Takenaka K, Matsumata T, Yoshida Y, Nishizaki T, Hasuo K, Sugimachi K. A 5-year experience of lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98-102[PMID: 2544499 DOI: S0270913989001254]
15. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, Fan ST, Wong J. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35: 1164-1171[PMID: 11981766 DOI: 10.1053/jhep.2002.33156]
16. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198: 33-40[PMID: 8539401]
17. Ong GY, Changchien CS, Lee CM, Wang JH, Tung HD, Chuah SK, Chiu KW, Chiou SS, Cheng YF, Lu SN. Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3878 procedures. Eur J Gastroenterol Hepatol 2004; 16: 737-742[PMID: 15256974 DOI: 00042737-200408000-00003]
18. Nagano M, Nakamura T, Niimi S, Fujino T, Nishimura T, Murayama N, Ishida S, Ozawa S, Saito Y, Sawada J. Substitution of arginine for cysteine 643 of the glucocorticoid receptor reduces its steroid-binding affinity and transcriptional activity. Cancer Lett 2002; 181: 109-114[PMID: 12430185]
19. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9: 6-19[PMID: 11803370 DOI: 10.1038/sj.cdd.4400969]
20. Li CP, Chao Y, Chen LT, Lee RC, Lee WP, Yuan JN, Yen SH, Lee SD. Fever after transcatheter arterial chemoembolization for hepatocellular carcinoma: incidence and risk factor analysis. Scand J Gastroenterol 2008; 43: 992-999[PMID: 19086281]
21. Wigmore SJ, Redhead DN, Thomson BN, Currie EJ, Parks RW, Madhavan KK, Garden OJ. Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer 2003; 89: 1423-1427[PMID: 14562011 DOI: 10.1038/ sj.bjc.6601329]
22. Shim JH, Park JW, Choi JI, Kim HB, Lee WJ, Kim CM. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma? J Vasc Interv Radiol 2009; 20: 209-216[PMID: 19084432 DOI: 10.1016/j.jvir.2008.10.021]
23. Hemingway AP, Allison DJ. Complications of embolization: analysis of 410 procedures. Radiology 1988; 166: 669-672[PMID: 3340761]
24. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148: 397-401[PMID: 6306721]
25. Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, Lencioni R. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev 2011; 37: 212-220[PMID: 20724077 DOI: 10.1016/j.ctrv.2010.07.006]